CINA CHEST vs Cleerly LABS
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for acute, life-threatening chest conditions in an emergency setting. This tool excels at quickly identifying suspected Pulmonary Embolism and Aortic Dissection on CT angiography scans, enabling faster prioritization of critical cases for radiologists and emergency teams.
View CINA CHEST →Choose Cleerly LABS if…
Choose Cleerly LABS if your focus is on comprehensive, personalized management of coronary artery disease, beyond acute triage. This software provides detailed AI-powered analysis of CCTA scans to quantify plaque, detect stenosis, and assess ischemia, supporting long-term risk stratification and tracking disease progression for individual patients.
View Cleerly LABS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | Cleerly LABS |
|---|---|---|
| Pricing | Subscription-based | Per analysis |
| Deployment | Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. |
| FDA Status | K210237 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools are web-based and designed for their specific use cases. CINA CHEST focuses on rapid, seamless integration into existing PACS/RIS workflows for emergency triage and notification, aiming for minimal user disruption. Cleerly LABS offers a rich, interactive web-based platform with 3D visualization and comprehensive reports for detailed diagnostic analysis and personalized patient education, providing a powerful interface for in-depth review.
Clinical Value
Cleerly LABSCleerly LABS offers a comprehensive, proactive approach to heart disease management by quantifying atherosclerosis and stenosis, aiming to personalize treatment and prevent future heart attacks. Clinical trials indicate its approach can reduce heart attacks by 41% in stable symptomatic patients. While CINA CHEST provides critical, rapid triage for acute, life-threatening conditions, Cleerly's impact on long-term disease prevention and personalized care demonstrates a broader clinical value.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent pricing information and has secured significant insurance coverage from major payors, including a Category I CPT code, which enhances its accessibility and value for patients and providers. CINA CHEST's pricing details are only available upon request, making a direct value comparison difficult without further information.
Enterprise Readiness
CINA CHESTCINA CHEST offers greater deployment flexibility, supporting cloud, on-premise, and virtualized environments, which caters to diverse hospital IT infrastructures. It also emphasizes seamless integration into existing PACS/RIS workflows via global standards like DICOM, HL7, and FHIR, minimizing disruption and IT burden. Both are FDA-cleared and HIPAA compliant.
Innovation
Cleerly LABSCleerly LABS offers a more transformative innovation by moving beyond traditional stenosis assessment to comprehensive plaque characterization, quantification, and tracking disease progression, aiming to proactively prevent heart attacks. This personalized, preventative approach to cardiovascular care represents a new standard of care. CINA CHEST's innovation is focused on rapid, accurate triage for acute emergencies.
Support & Docs
Cleerly LABSCleerly LABS explicitly states its support hours (Monday-Friday, 10 am ET to 6 pm ET) and provides a dedicated client support channel for existing users. Information regarding specific support and documentation for CINA CHEST is not readily available in the provided data or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | Cleerly LABS |
|---|---|---|
| Name | CINA CHEST | Cleerly LABS |
| Company | Avicenna.AI | Cleerly |
| Description | FDA-cleared AI-powered radiological triage and notification software by Avicenna.AI, designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. |
| Primary Use Case | Rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis. |
| Key Features (Examples) | Radiological computer-aided triage and notification, Detection of Pulmonary Embolism (PE) on Chest CT angiography, Detection of Aortic Dissection (AD) on Chest or Thoraco-abdominal CT angiography | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and Cleerly LABS.
Frequently Asked Questions
More Comparisons
More matchups featuring CINA CHEST or Cleerly LABS
Backers
Who funded each tool's parent company.